Stokes Peebles

Stokes Peebles, MD, right, Mark Rusznak, PhD, and their colleagues have identified a potential drug target for treating asthma. (photo by Erin O. Smith)
February 4, 2026

Broad genetic study reveals new drug target for asthma

The findings could bring relief to the more than 26 million people in the United States with asthma, a chronic and complex inflammatory disease of the airways.

By Bill Snyder
September 11, 2025

Stokes Peebles steps down as section chief of Allergy after 15 Years of leadership

During his tenure, he grew the section into a nationally recognized center for excellence in clinical care, research and education.

By Kylie Avery
This year’s awardees are, from left, Stokes Peebles, MD, Ravi Shah, MD, John Gore, PhD, and Jeffrey Davidson, PhD. (photo by Erin O. Smith)
February 14, 2025

VUMC honors four translational scientists

Translational research brings discoveries from the laboratory and preclinical studies to clinical trials and studies in humans.

By Bill Snyder
January 24, 2024

Stokes Peebles appointed to the National Advisory Allergy and Infectious Diseases Council

Vanderbilt’s Stokes Peebles, MD, has been appointed to the National Advisory Allergy and Infectious Diseases Council.

By Bill Snyder
A clinical trial supports approval of a new medication to treat moderate-to-severe asthma in children.
April 24, 2023

Study finds early RSV infection linked to significantly increased risk of asthma in children

A Vanderbilt study has found that RSV infection in the first year of life is associated with a significantly increased risk of asthma in children.

By Nancy Humphrey
March 9, 2023

Study finds RSV may evade vaccines via rapid mutation

A Vanderbilt study concluded that RSV’s ability to mutate rapidly to escape detection by the body’s immune system makes it more challenging to design and develop vaccines that can stop it from spreading.

By Bill Snyder
November 10, 2022

Clinical trial at VUMC tests novel treatment for asthma

VUMC has begun enrolling patients with asthma in a clinical trial of a novel treatment: a medication approved to treat diabetes and obesity.
By Leigh MacMillan
July 21, 2022

Study explores role RSV plays in later asthma development

A Vanderbilt clinical project will follow 1,950 Middle Tennessee children to determine how genes and the environment interact with RSV infection during the first year of life and contribute to asthma development
By Leah Mann
April 21, 2022

Drake, Freedman, Peebles elected AAP members

Vanderbilt's Wonder Drake, MD, Jane Freedman, MD, and Stokes Peebles, MD, have been elected to membership in the Association of American Physicians (AAP), one of the nation’s most respected medical honor societies.
By Kathy Whitney
March 25, 2021

Team studies new use for pulmonary hypertension drug

An FDA-approved medication enhances the function of T regulatory cells (Treg), a class of immune cells that restrains the immune response, Vanderbilt investigators have discovered.
By Leigh MacMillan
October 8, 2019

A new regulator of B cell development

New findings establish a role for the pro-inflammatory molecule IL-33 in the early development of antibody-producing B cells.
By Leigh MacMillan
August 2, 2018

Connecting an asthma gene to leukemia

A receptor previously implicated in asthma may also play roles in other allergic diseases and in leukemia, Vanderbilt researchers have discovered.
By Leigh MacMillan
July 12, 2018

Team explores diabetes drug’s ability to treat RSV infection

A drug used to treat diabetes may point to new therapies for respiratory syncytial virus (RSV) bronchiolitis — inflammation and obstruction of the lungs’ small airways. A multi-disciplinary team of Vanderbilt investigators has demonstrated that liraglutide reduces the inflammatory response to RSV infection in a mouse model of the disease.
By Leigh MacMillan
1 2